Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

The Lancet Neurology
May 16, 2017
Cited by 918

Abstract


Related Papers

No related papers found

Powered by citation graph analysis